News for Providers
Top stories summarized by our editors
11/15/2019

Researchers developed a risk-adapted starting age strategy for breast cancer screening based on data from more than 5 million Swedish women and found that those with a family history of breast cancer might need to begin undergoing screening up to 14 years earlier than recommended national guidelines. The findings, published in JAMA Oncology, showed that screening women with a family history of breast cancer "under the existing guidelines represents missed opportunities for early detection of early-onset breast cancer in women at increased risk owing to family history," researchers wrote.

11/15/2019

A study published in Diabetes Care found that patients with diabetic ketoacidosis and a hyperosmolar hyperglycemic state upon hospital arrival had higher mortality rates, compared with patients who had only DKA or HHS. Using data from 1,211 patients, the researchers also found that DKA-HHS patients who developed hypoglycemia or hypokalemia within 48 hours of hospital admission were 4.8 times and 4.9 times more likely to die, respectively, and suggested that there need to be "effective protocols to closely monitor both glucose and potassium levels during insulin therapy."

Full Story:
MedWire News (U.K.)
11/15/2019

A survey conducted by The Harris Poll and commissioned by the National Kidney Foundation found that 46% of 2,000 American adults did not know that diabetes is tied to an increased risk for kidney failure, 31% did not know that diabetes increases kidney disease risk and 14% of survey participants who had diabetes were either "unsure" or "did not believe" that diabetes increases the risk of kidney disease. The poll also found that younger adults were more likely to be wrong or unsure about the association of diabetes and kidney disease.

11/15/2019

An FDA advisory panel voted against the use of empagliflozin, an SGLT2 inhibitor, as an adjunct to insulin therapy in patients with type 1 diabetes. The potential risk of diabetic ketoacidosis with higher doses led the panel to say that the data did not show that the treatment's benefits outweigh the risks and an additional study is needed.

Full Story:
Reuters
11/15/2019

US Sen. Mike Braun, R-Ind., said during an interview about health care in 2020 that Republicans could be on the wrong side of history with Medicare for All if they can't convince the health care industry to enact its own reforms. HHS Secretary Alex Azar said too much time is spent discussing the Affordable Care Act, which is a small part of US health care, when the focus should be protecting what works and making it better.

Full Story:
Axios
More Summaries:
Sen. Mike Braun
11/15/2019

A $50 million venture capital fund will be created by the American Hospital Association and Concord Health Partners to invest in early-stage health care startups. Children's National Health System and Virginia Tech said they will jointly build a Virginia Tech biomedical research facility at the Children's National Research & Innovation Campus.

More Summaries:
Virginia Tech
11/15/2019

Swedish researchers developed the Adjuvant Radiotherapy Intensification Classifier, which is based on patient age and made up of 27 genes, to identify who among the women with early-stage breast cancer would benefit from adjuvant whole-breast radiotherapy and those who are at an increased risk for locoregional recurrence. The findings in the Journal of Clinical Oncology, based on 748 women from the SweBCG91-RT trial, showed that low ARTIC scores were associated with a higher radiotherapy benefit and lower local and regional recurrences.

11/15/2019

A study published in Oncology Nursing Forum found that breast cancer survivors were more likely to discontinue regular mammogram screening due to 19 factors, including individual factors such as age, cancer stage and ethnicity, and health care system factors such as medical home program enrollment, health care provider and travel time to access health services. "Awareness of these factors may be valuable in clinical practice for taking pre-emptive action, by identifying women likely to be at higher risk of nonadherence," researchers wrote.

11/15/2019

The legal age to purchase tobacco and e-cigarette products in New York has now been raised to 21 in order to prevent these products "from getting into the hands of our youth, creating an addiction to a deadly habit," according to statement released by Gov. Andrew Cuomo. Meanwhile, lawmakers in New Jersey are scheduled to vote on several anti-vaping measures, including one on imposing penalties against vendors who would sell vaping products to minors, in response to a national vaping health epidemic.

More Summaries:
Vaping
11/15/2019

Artificial intelligence is playing an increasingly important role in health care by analyzing medical images, easing the exchange of medical expertise, automating laborious tasks and predicting when and how patients get sick, but the technology also comes with risks such as low data integrity, privacy issues and bias, writes W. Nicholson Price III, a professor of law at the University of Michigan Law School. The FDA doesn't oversee all health care AI systems, so Price suggests that health systems and professional organizations like the ACR bolster oversight efforts to ensure system quality.